🇺🇸 FDA
Pipeline program

Immune Globulin 10% Intravenous Solution

1001

Phase 3 small_molecule active

Quick answer

Immune Globulin 10% Intravenous Solution for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a Phase 3 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials